Meadow Creek Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.34M | Sell |
8,428
-112
| -1% | -$31.1K | 0.05% | 306 |
|
|
2019
Q2 | $2.67M | Sell |
8,540
-7,056
| -45% | -$2.21M | 0.05% | 290 |
|
|
2019
Q1 | $6.4M | Buy |
15,596
+10,500
| +206% | +$4.31M | 0.13% | 147 |
|
|
2018
Q4 | $1.9M | Buy |
5,096
+1,372
| +37% | +$513K | 0.04% | 315 |
|
|
2018
Q3 | $1.51M | Buy |
3,724
+840
| +29% | +$339K | 0.03% | 371 |
|
|
2018
Q2 | $995K | Buy |
2,884
+56
| +2% | +$19.3K | 0.02% | 436 |
|
|
2018
Q1 | $974K | Sell |
2,828
-476
| -14% | -$164K | 0.02% | 435 |
|
|
2017
Q4 | $1.24M | Buy |
3,304
+1,540
| +87% | +$579K | 0.03% | 407 |
|
|
2017
Q3 | $789K | Sell |
1,764
-84
| -5% | -$37.6K | 0.02% | 481 |
|
|
2017
Q2 | $908K | Sell |
1,848
-196
| -10% | -$96.3K | 0.02% | 434 |
|
|
2017
Q1 | $792K | Sell |
2,044
-28
| -1% | -$10.8K | 0.02% | 437 |
|
|
2016
Q4 | $760K | Buy |
+2,072
| New | +$760K | 0.02% | 424 |
|